DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - KEMPHARM INC ownership

KEMPHARM INC's ticker is and the CUSIP is 488445AB3. A total of 3 filers reported holding KEMPHARM INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of KEMPHARM INC
ValueSharesWeighting
Q3 2019$32,179,000
+1.7%
62,423,000
-4.6%
1.31%
+15.5%
Q2 2019$31,632,000
+10.3%
65,423,0000.0%1.14%
+3.3%
Q1 2019$28,677,000
-27.1%
65,423,0000.0%1.10%
-30.2%
Q4 2018$39,363,000
-18.5%
65,423,000
-12.8%
1.58%
-8.8%
Q3 2018$48,281,000
-12.9%
75,000,0000.0%1.73%
-11.2%
Q2 2018$55,438,000
-3.2%
75,000,0000.0%1.95%
-1.9%
Q1 2018$57,250,000
+25.1%
75,000,0000.0%1.98%
+10.2%
Q4 2017$45,750,000
+0.1%
75,000,0000.0%1.80%
-12.5%
Q3 2017$45,688,000
+3.2%
75,000,0000.0%2.06%
-12.8%
Q2 2017$44,250,000
-3.2%
75,000,0000.0%2.36%
+33.9%
Q1 2017$45,719,00075,000,0001.76%
Other shareholders
KEMPHARM INC shareholders Q1 2018
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 75,000,000$57,250,0001.98%
DSC Advisors, L.P. 8,250,000$6,112,0001.28%
KINGDON CAPITAL MANAGEMENT, L.L.C. 3,000,000$2,065,0000.16%
View complete list of KEMPHARM INC shareholders